logo

Sutro Biopharma Inc (STRO)



Trade STRO now with
  Date
  Headline
3/16/2020 7:21:33 AM Sutro Biopharma FY Net Loss Widens To $55.7 Mln From $35.3 Mln Last Year
3/12/2020 7:07:10 AM Sutro Biopharma Extends First Cytokine Derivative Research Program Under Collaboration With Merck By One Year
1/8/2020 9:27:57 AM Sutro Biopharma Adds James Panek To Board
11/8/2019 7:07:07 AM Sutro Biopharma Q3 Loss Per Share $0.56 Vs Loss $21.26 Last Year
8/14/2019 6:24:42 AM Sutro Biopharma Q2 Revenue $10.5 Mln Vs $5.7 Mln Last Year
6/24/2019 4:12:39 PM Sutro Biopharma Appoints Connie Matsui As Board Chair
6/15/2019 6:05:48 AM Sutro Biopharma Announces Encouraging Interim Phase 1 Safety Data Of STRO-001 For B-cell Malignancies
4/2/2019 7:11:26 AM Wedbush Is Cutting SUTRO BIOPHARMA INC (STRO) Q4 19 Rev. Estimate To 11.3 M From 23.8 M
4/2/2019 7:11:13 AM Wedbush Is Cutting SUTRO BIOPHARMA INC (STRO) Q3 19 Rev. Estimate To 11.3 M From 13.8 M
4/2/2019 7:11:00 AM Wedbush Is Increasing SUTRO BIOPHARMA INC (STRO) Q2 19 Rev. Estimate To 11.3 M From 3.8 M
4/2/2019 7:10:51 AM Wedbush Is Increasing SUTRO BIOPHARMA INC (STRO) Q1 19 Rev. Estimate To 11.3 M From 3.8 M
4/2/2019 7:10:27 AM Wedbush Is Cutting SUTRO BIOPHARMA INC (STRO) FY19 Estimate To -2.34 From -1.89
4/2/2019 7:10:15 AM Wedbush Is Cutting SUTRO BIOPHARMA INC (STRO) Q4 19 Estimate To -0.62 From -0.01
4/2/2019 7:09:57 AM Wedbush Is Lowering SUTRO BIOPHARMA INC (STRO) Q3 19 Estimate To -0.56 From -0.33
4/2/2019 7:09:43 AM Wedbush Is Increasing SUTRO BIOPHARMA INC (STRO) Q2 19 Estimate To -0.61 From -0.80
4/2/2019 7:09:30 AM Wedbush Is Raising SUTRO BIOPHARMA INC (STRO) Q1 19 Estimate To -0.55 From -0.76